Terns Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.10 Insider Own0.10% Shs Outstand38.51M Perf Week6.30%
Market Cap246.86M Forward P/E- EPS next Y-1.89 Insider Trans- Shs Float35.95M Perf Month-10.60%
Income-58.80M PEG- EPS next Q-0.47 Inst Own98.20% Short Float / Ratio1.41% / 1.91 Perf Quarter72.78%
Sales1.00M P/S246.86 EPS this Y-71.00% Inst Trans70.13% Short Interest0.51M Perf Half Y262.15%
Book/sh4.77 P/B1.34 EPS next Y5.00% ROA-35.50% Target Price7.00 Perf Year-16.75%
Cash/sh4.86 P/C1.32 EPS next 5Y- ROE-37.30% 52W Range1.45 - 7.92 Perf YTD-9.34%
Dividend- P/FCF- EPS past 5Y- ROI-31.40% 52W High-19.07% Beta-
Dividend %- Quick Ratio25.50 Sales past 5Y- Gross Margin- 52W Low342.07% ATR0.79
Employees41 Current Ratio25.50 Sales Q/Q- Oper. Margin- RSI (14)52.77 Volatility17.47% 14.05%
OptionableNo Debt/Eq0.00 EPS Q/Q7.20% Profit Margin- Rel Volume0.48 Prev Close6.97
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout- Avg Volume265.28K Price6.41
Recom2.50 SMA209.15% SMA504.00% SMA20075.15% Volume126,927 Change-8.03%
Sep-12-22Initiated H.C. Wainwright Neutral $6
Sep-14-21Resumed Goldman Buy $21
Mar-02-21Initiated JP Morgan Overweight $32
Mar-02-21Initiated Goldman Buy $29
Mar-02-21Initiated Cowen Outperform
Dec-01-22 04:05PM
Nov-16-22 09:31AM
Nov-09-22 04:05PM
Nov-04-22 08:05AM
Oct-26-22 04:05PM
05:26AM Loading…
Oct-12-22 05:26AM
Oct-11-22 04:05PM
Sep-29-22 06:03AM
Sep-21-22 05:33AM
Sep-07-22 04:05PM
Aug-19-22 06:50AM
Aug-12-22 08:00AM
Aug-08-22 04:05PM
Jul-27-22 04:05PM
Jul-22-22 12:00PM
04:05PM Loading…
Jun-22-22 04:05PM
Jun-09-22 06:31AM
Jun-08-22 04:05PM
Jun-01-22 04:05PM
May-16-22 04:05PM
Apr-05-22 01:38PM
Apr-04-22 04:05PM
Mar-21-22 04:05PM
Mar-03-22 04:05PM
Feb-28-22 04:05PM
Feb-04-22 11:37AM
Feb-02-22 05:38PM
Jan-06-22 07:05AM
Jan-03-22 04:05PM
Nov-15-21 04:05PM
07:05AM Loading…
Nov-12-21 07:05AM
Nov-10-21 07:17AM
Nov-09-21 04:05PM
Nov-03-21 02:52PM
Oct-18-21 04:05PM
Oct-05-21 04:05PM
Oct-04-21 08:38AM
Sep-28-21 04:05PM
Sep-15-21 06:07PM
Sep-08-21 07:05AM
Sep-02-21 04:05PM
Aug-16-21 04:05PM
Aug-03-21 04:05PM
Jun-24-21 04:05PM
Jun-14-21 12:41PM
Jun-13-21 05:00PM
May-19-21 05:00PM
May-13-21 04:05PM
May-06-21 08:59AM
Apr-07-21 07:05AM
Mar-30-21 04:05PM
Mar-26-21 07:31AM
Mar-22-21 07:35AM
Mar-08-21 07:00AM
Mar-01-21 03:20PM
Feb-23-21 04:35PM
Feb-14-21 06:01AM
Feb-12-21 10:58AM
Feb-11-21 08:30AM
Feb-10-21 07:05AM
Feb-09-21 09:00AM
Feb-08-21 09:18AM
Feb-04-21 06:54PM
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAV Biosciences Fund V, L.P.10% OwnerNov 23Sale5.501,500,0008,250,000405,583Nov 28 04:56 PM
Lu HongboDirectorSep 07Buy3.60600,0002,160,0003,581,592Sep 08 08:00 PM
Vivo Opportunity, LLC10% OwnerSep 07Buy3.60600,0002,160,0003,581,592Sep 08 08:00 PM
ORBIMED ADVISORS LLCDirectorAug 16Buy2.423,690,0008,929,8004,744,923Aug 18 05:00 PM
GORDON CARL LDirectorAug 16Buy2.423,690,0008,929,8004,744,923Aug 18 04:50 PM
Vivo Opportunity, LLC10% OwnerAug 16Buy2.421,500,0003,630,0002,981,592Aug 16 08:44 PM
Lu HongboDirectorAug 16Buy2.421,500,0003,630,0002,981,592Aug 16 08:30 PM
Lu HongboDirectorAug 15Buy2.991,2183,6421,481,592Aug 16 08:30 PM
Vivo Opportunity, LLC10% OwnerAug 15Buy2.991,2183,6421,481,592Aug 16 08:44 PM
Vivo Opportunity, LLC10% OwnerAug 12Buy2.981,123,0213,346,6031,480,374Aug 16 08:44 PM
Lu HongboDirectorAug 12Buy2.981,123,0213,346,6031,480,374Aug 16 08:30 PM